F/M Emerald Life Sciences Innovation ETF (LFSC)

Assets	$42.43M
Expense Ratio	0.54%
PE Ratio	n/a
Shares Out	2.21M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Ratio	n/a
1-Year Return	n/a

Volume	6,357
Open	20.00
Previous Close	20.69
Day's Range	19.86 - 20.00
52-Week Low	18.78
52-Week High	27.76
Beta	n/a
Holdings	33
Inception Date	Oct 31, 2024

About LFSC

Fund Home Page

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: LFSC
• ETF Provider: F/m Investments

Top 10 Holdings

55.92% of assets

Name	Symbol	Weight
BridgeBio Pharma, Inc.	BBIO	7.34%
Soleno Therapeutics, Inc.	SLNO	7.05%
RadNet, Inc.	RDNT	6.52%
Blueprint Medicines Corporation	BPMC	6.21%
Merit Medical Systems, Inc.	MMSI	5.77%
Travere Therapeutics, Inc.	TVTX	4.92%
LivaNova PLC	LIVN	4.92%
Collegium Pharmaceutical, Inc.	COLL	4.65%
TransMedics Group, Inc.	TMDX	4.27%
Ultragenyx Pharmaceutical Inc.	RARE	4.27%